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The genus Arcobacter has become increasingly important in recent years because its 
members have been considered emergent enteropathogens and potential zoonotic agents 
(Ho et al., 2006). 
This genus is an atypical group within the epsilon subdivision of the proteobacteria 
because of its wide diversity of habitats and hosts (Wesley et al., 2010). Some Arcobacter 
species have been detected in or isolated from stools of patients with and without 
diarrhoea and occasionally in association with bacteraemia, endocarditis, and peritonitis 
(Abdelbaqi et al., 2007). In animals, Arcobacter have been implicated in abortions, 
mastitis, and gastrointestinal disorders but have also been recovered from asymptomatic 
animals (Vandamme et al., 1992; Van Driessche et al., 2003). Despite that, the incidence 
of Arcobacter species is probably underestimated, due mainly to limitations in current 
detection and identification methods (Vandenberg et al., 2004). 
In recent years considerable progress has been made in understanding the taxonomy and 
pathogenicity of this group of microorganisms, and  important new contributions have 
been published, such as the complete genome of Arcobacter butzleri from a human 
clinical strain, which revealed detailed information about the physiology and genetics of 
this organism (Miller et al., 2007). This is the most important and prevalent species of the 
genus; it has been classified as a serious hazard to human health by the International 
Commission on Microbiological Specifications for Foods and as a significant zoonotic 
pathogen (Cardoen et al., 2009). 
The genus Arcobacter was proposed in 1991 to accommodate two aerotolerant 
Campylobacter species: Campylobacter cryaerophila (now Arcobacter cryaerophilus) 
and Campylobacter nitrofigilis (now Arcobacter nitrofigilis). Formerly was isolated from 
diverse origins (i.e., from the faeces, reproductive tracts, and aborted foetuses of several 
farm animals and from the milk of cows with mastitis (Neill et al., 1985). The latter 
species is a nitrogen-fixing bacterium isolated from the roots and root-associated 
sediments of Spartina alterniflora, a salt marsh plant (McClung et al., 1983). Later, the 
genus was amended and enlarged, with the reclassification of Campylobacter butzleri as 
Arcobacter butzleri and with the description of the new species Arcobacter skirrowii 
(Vandamme et al., 1992) 
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Arcobacter butzleri was originally isolated from humans and animals with diarrhoea 
(Kiehlbauch et al., 1991), while A. skirrowii was obtained from the faeces of lambs with 
diarrhoea, aborted porcine, ovine, and bovine foetuses, and from bulls prepuce. Within 
the species A. cryaerophilus, two groups (named either 1A and 1B or 1 and 2) were 
defined based on different restriction fragment length polymorphisms (RFLP) of the 16S 
and 23S rRNA genes (Kiehlbauch et al., 1991) and on whole-cell protein and fatty acid 
contents (Vandamme et al., 1992). Moreover, these groups were found to cluster 
separately using amplified fragment length polymorphism (AFLP) analysis (On et al., 
2003). The A. cryaerophilus group 1B is much more prevalent than 1A (Collado et al., 
2009), and the two groups have been simultaneously isolated only from food products 
and from animal and human clinical samples (Kabeya et al., 2003). Some studies 
indicated the need to clarify whether these two groups belong to two separate taxa 
(Debruyne et al., 2008). Regarding this, the taxonomy of these two groups of A. 
cryaerophilus strains has recently been investigated using AFLP and the sequences of the 
hsp60 gene: results suggested that the discrimination in groups should be abandoned and 
that the current type strain of this species (LMG 24291T) should be exchanged for LMG 
10829, which is more representative of the species (Debruyne et al., 2010). 
The species Arcobacter cibarius was isolated from broiler carcasses in Belgium (Houf et 
al., 2005), and Arcobacter halophilus was described on the basis of a unique strain 
recovered from a hyper-saline lagoon in Hawaii (Donachie et al., 2005), representing the 
first obligate halophilic Arcobacter species. Over the years, new species belonging to the 
genus Arcobacter, which now includes 17 species, were described.  Arcobacter mytili, 
isolated from mussels and brackish water in Spain, was the first species of the genus that 
is unable to hydrolyze indoxyl acetate  (Collado et al., 2009), Arcobacter thereius has 
been isolated from livers and kidneys of spontaneously aborted porcines and from duck 
cloacal samples (Houf et al., 2009), Arcobacter marinus (reported on the basis of a 
unique strain) has been isolated from a mixed sample of seawater, starfish and seaweeds 
in Korea (Kim et al., 2010), Arcobacter trophiarum was isolated from faeces of fattening 
pigs in Belgium (De Smet et al., 2010), Arcobacter defluvii was isolated from sewage 
samples and Arcobacter molluscorum was recovered from mussels and oysters and is the 
second species of the genus that does not hydrolyze indoxyl acetate. One strain isolated 
from a chicken cloacal swab sample in Valdivia (Chile) showed 99.9% 16S rRNA gene 
similarity (GenBank accession number GU300768) with the sequence of the type strain 
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of A. trophiarum, indicating that the strain, recovered from a different origin and region, 
belonged to this new species (Figueras et al., 2011). An obligate microaerophilic 
organism that oxidizes sulfides was proposed as a potential new species, “Candidatus 
Arcobacter sulfidicus” (Wirsen et al., 2002.), but a formal description does not exist yet. 
In the last years the new species Arcobacter ellisii isolated from mussels (Figueras et al., 
2011), Arcobacter bivalviorum and Arcobacter venerupis from shellfish (Levican et al., 
2012), Arcobacter suis and Arcobacter cloacae from food and sewage (Levican A. et al., 
2013) were described. 
The taxonomy of the genus Arcobacter, like those of other bacterial genera, has been 
based on the analysis of the 16S rRNA gene (Wesley et al., 1995). The analysis of the 
16S rRNA gene sequences deposited in GenBank indicates that there are many 
potentially new Arcobacter species that have yet to be characterized. Some Arcobacter 
housekeeping genes, such as gyrA (Abdelbaqi et al., 2007) and rpoB-rpoC (Morita et al., 
2004), have been investigated to better differentiate the species and their phylogenetic 
relationships. However, in only a few recent studies, using the rpoB (Collado et al., 
2011), gyrB (Figueras et al., 2010), and hsp60 genes has the phylogeny of the genus been 
evaluated using all the type strains of the accepted species. The results from these genes 
were congruent with the 16S rRNA gene-based phylogeny (Collado et al., 2009), and 
they showed lower intra- and interspecies similarities and therefore a higher 
discriminatory power. Figure 1 shows the 16S rRNA gene phylogenetic relationships of 
the presently described species. These potentially new Arcobacter species come from 
very different hosts and/or habitats, i.e., activated sludge and sewage, oil field 
environments, tidal and marine sediments, seawater, estuarine and river water, plankton, 
coral, tubeworms, snails, oysters, abalone, and associated with cod larviculture or with 
cyanobacterial mats (Romero et al., 2002). Although most of them are sequences from 
uncultured bacteria, it is likely that several new species will be proposed in the near 
future. All these provide evidence that Arcobacter species inhabit very diverse 




FIG. 1. Neighbour-joining phylogenetic tree showing the relationship of the described Arcobacter species 
on the basis of the 16S rRNA gene. From: A. Levican et al. (2013). 
 
1.1 General characteristics of the genus Arcobacter 
 
The genus Arcobacter include Gram negative, non-spore-forming, motile and spiral 
shaped rods, with a size ranging between 0,2-0.9 m wide and 1-3 m long, although 
waterborne arcobacters were found to be larger (Wirsen et al., 2002). They are motile and 
have one unsheathed polar ﬂagellum at one or both ends of the cells (Vandamme, 2000). 
They differ from Campylobacter spp. by their ability to grow at lower temperatures (15 
°C compared with 30 °C) in aerobic environment, after primary isolation under 
microaerophilic conditions (Mansfield et al., 2000).  
Arcobacter species are oxidase and catalase positive. Other biochemical results revealed 
positivity to indoxyl acetate hydrolysis test and nitrate reduction test, and negativity to 
urease test, hippurate hydrolysis test and H2S production from triple sugar iron agar (TSI) 
(Patyal et al., 2011). 
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Arcobacter butzleri is the best characterized species of the genus, its cells are small, 
spiral and motile, morphologically similar to the taxonomically–related Campylobacter. 
Nonetheless, notable differences exist between A. butzleri and Campylobacter spp. 
Initially described as an ‘‘aerotolerant Campylobacter’’, along with A. cryaerophilus, A. 
butzleri is able to grow aerobically, unlike most Campylobacter species which are 
microaerophilic. However, A. butzleri grows also under microaerophilic and anaerobic 
conditions (Forsythe et al., 2006), thus tolerating a wide range of oxygen concentrations.  
Additionally, Campylobacter spp. grow generally between 37 °C and 42 °C (Mandrell et 
al., 2006), whereas A. butzleri is psychrophilic, with a temperature range between 15 °C 
and 37 °C, although some strains can grow at 42 °C (Forsythe et al., 2006). Furthermore, 
A. butzleri is more halotolerant than most Campylobacter spp., with some strains able to 
grow at 3.5% NaCl. The optimum pH for growth is 6.0 to 7.0 (A. butzleri), 7.0 to 7.5 (A. 
cryaerophlilus), ranging between 5.0 and 8.5.  
 
Table 1shows the differential characteristics of genus Arcobacter. 
 
Table 1. Differential characteristic of Arcobacter species. From: A. Levican et al. (2013). 
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1.2 Isolation procedures for Arcobacter 
 
Like Campylobacter, routine identification of Arcobacter is difficult because these 
organisms have fastidious growth requirements and are relatively biochemically inert 
(Kiehlbauch et al.,1991). Moreover, since Arcobacter and Campylobacter species show 
several morphological and biochemical similarities, incorrect detection and identification 
of Arcobacter might occur when relying on conventional plating methods and phenotypic 
tests. This may lead to a substantial underestimation of the true incidence of Arcobacter 
species in food commodities and in animal and human illnesses (Harrab et al. 1998). 
Since the first isolation protocol was developed (Ellis et al., 1977), several enrichment 
and plating formulations have been devised for the selective recovery and detection of 
Arcobacter species in foods (Collins et al., 1996; de Boer et al., 1996; Corry et al.,1997; 
Johnson, 1999;). 
The first isolate of Arcobacter (at that time called a Spirillum/Vibrio-like organism) was 
recovered in 1977 from aborted bovine fetuses by using the Ellinghausen-McCullough-
Johnson- Harris (EMJH) Leptospira medium (Ellis et al., 1977). One of the most 
commonly employed Arcobacter isolation protocols is based on the use of an enrichment 
broth supplemented with cefoperazone, amphotericin B and teicoplanin, known as CAT 
broth, followed by passive filtration of the broth through a 0.45-m filter placed over 
blood agar (Atabay et al., 1997). Johnson and Murano (1999) proposed a new enrichment 
broth and isolation medium with cefoperazone and 5-fluorouracil as selective 
supplements, obtaining good recovery of Arcobacter and strong inhibition of other 
bacteria.  
Another very popular method was designed after an antimicrobial Arcobacter 
susceptibility study by Houf et al. (2001) and consists of a selective isolation protocol 
that incorporates five antibiotics in both the enrichment and the plating medium. This is 
the only method that has been validated for faecal specimens, by evaluating the recovery 
of arcobacters from artificially contaminated faecal samples (Houf et al., 2007). Van 
Driessche et al. (2003) modified the enrichment and plating medium described by Houf 
et al. (2001), adding cycloheximide (100 mg l
-1
) and increasing the novobiocin 
concentration (from 32 to 64 mg liter
-1
). Recently, Scullion et al. (2006), combining the 
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methods of Houf et al. (2001) and Johnson and Murano (1999) obtained 25% more 
positive samples from packed retail poultry than when using each method independently.  
The most common procedures for the isolation of Arcobacter and other campylobacters 
from human clinical samples are the combination of sample filtration over an antibiotic-
free blood agar plate (to eliminate larger accompanying microbes) and inoculation of the 
samples directly onto a selective medium in parallel (Lastovica et al., 2000; Abdelbaqi et 
al., 2007). Interestingly, the use of an enrichment step before filtration increased 
Campylobacter detection by 38.5% (Wilson et al., 2007), and it is likely that the same 
could occur for arcobacters. However, it has been reported that the enrichment step 
reduces the diversity of Arcobacter species recovered in the plating medium in 
comparison with direct plating, promoting the fast-growing species (Houf et al.,2002; Ho 
et al., 2006).  
In summary, the methods for recovering Arcobacter are very diverse and that there is a 
lack of consensus about which of them is the most useful (depending on the type of 
sample), because few comparative studies have been performed (Andersen et al., 2007) 
and, to our knowledge, there is no study in which they were all compared simultaneously. 
Some of the recovery problems reported include the inhibition of some Arcobacter 
species when using certain antibiotics (Atabay et al., 2006) and insufficient inhibition of 
the accompanying microbiota (Ho et al., 2006; Andersen et al., 2007).  
Generally, although not in clinical microbiology, Arcobacter isolation includes an 
enrichment step (which usually takes 48 h) in a broth containing several antibiotics 
followed by isolation on agar media (with or without antibiotics) for an additional 
incubation period of 48 to 72 h.  
 
1.3 Arcobacter virulence factors 
 
The pathogenicity and virulence mechanisms of Arcobacter species are still poorly 
understood, despite several studies investigated their adhesion capacity, invasiveness, and 
cytotoxicity in different cell lines. Their in vitro ability to invade human/animal cell lines 
has been demonstrated mainly for the species A. cryaerophilus, whereas A. butzleri has 
been reported as the most invasive species in experimental animal infections (Fernandez 
et al., 1995; Wesley et al., 1996).  
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The virulence of A. cryaerophilus was mainly associated to the induction of fluid and 
electrolytes accumulation in the rat ileal loop assay and to in vitro invasion of Hep-2 cells 
(Fernandez et al.,1995). This species seems to be more virulent for animals than other 
Arcobacter species, since it is able to invade both the porcine intestinal tissues and the 
placenta, disseminating to the foetus, as demonstrated in infections in sows, transmitted 
to their offspring (Ho et al., 2006). Other studies have demonstrated that A. butzleri 
strains colonized the intestines of all the experimentally infected piglets, but contrasting 
results were obtained for chickens and turkeys (Wesley et al., 1996). It was also 
evidenced that the Beltsville White turkey was the most suitable animal model for the 
study of diarrhoeal infection (Wesley et al.,1999), although several other animal models 
and in vivo experiments have been used (Wesley et al., 2010).  
The presence of adhesion molecules in A. butzleri was evidenced by strains ability to 
agglutinate human, rabbit and sheep erythrocytes, and a hemagglutinin of about 20 
kilodaltons (kDa) has been characterized by Western immunoblotting analyses (Tsang et 
al., 1996). This hemagglutinin is a lectin-like molecule, which is able to interact with 
erythrocyte receptors containing D-galactose. The mechanism by which A. butzleri 
induces diarrhoea has been studied by infecting human colonic epithelial cells (HT-
29/B6) (Bücker et al., 2009). The results indicated that the process was mediated by a 
reduced expression of claudin-1, -5, and -8 tight-junction proteins, which generated an 
epithelial barrier dysfunction and apoptosis of those cells, resulting in a leak flux type of 
diarrhoea (Bücker et al., 2009).  
The induced expression of the proinflammatory cytokine interleukin-8 (IL-8) is 
considered a major virulence factor of H. pylori and Campylobacter spp. and has also 
been reported for A. butzleri, A. cryaerophilus, A. skirrowii, and A. cibarius (Ho et al., 
2007). However, despite the fact that all tested Arcobacter strains show the ability to 
induce IL-8 production by human Caco-2 cells and porcine intestinal epithelial cells, no 
correlation with levels of cell adhesion or invasion was found (Ho et al., 2007). 
 
1.4 Arcobacter transmission routes 
 
Consumption of Arcobacter-contaminated food or water is considered the main route of 
transmission to human and animals (Ho et al., 2006). In addition, Arcobacter species 
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have been defined as potential zoonotic agents due to their pathogenic role in humans and 
animals and using an evidence-based semi-quantitative method for prioritization of food-
borne zoonoses, A. butzleri was ranked as a microbe of significant importance (Cardoen 
et al., 2009). Direct transmission between humans and animals has not been demonstrated 
yet.  
Arcobacter strains tolerate high sodium chloride concentrations, grow at low refrigeration 
temperatures, have the ability to attach to various types of surfaces and are not very 
susceptible to desiccation. However, a study aimed at assaying chemical and physical 
treatments able to control or eliminate arcobacters from food and water demonstrated that 
a heat treatment (50°C) followed by cold shock (4 or 8 °C) produced a lethal synergistic 
effect, by reducing the number of living Arcobacter cells more than single heat or cold 
treatments (D’Sa et al., 2005). 
 
1.4.1 Arcobacter in water 
 
Water is a possible route of transmission of arcobacters to animals and humans. Members 
of this genus have been recovered from several types of environmental waters, i.e., rivers, 
lakes, groundwater and seawater, as well as from plankton (Collado et al., 2008). It was 
recently hypothesized that Arcobacter species are autochthonous to aquatic environments 
(Fera et al., 2004), although a high prevalence of these bacteria has also been observed in 
faeces of livestock animals (Van Driessche et al., 2003) and in farm effluents 
(Chinivasagam et al., 2007). This could indicate that those are the sources of surface 
water contamination. In fact, A. butzleri, A. cryaerophilus and A. skirrowii occurrence in 
water showing faecal contamination is more frequent than in other water samples 
(Collado et al., 2009).  
These species enter seawater with the polluted freshwater, where they are probably able 
to coexist with other indigenous species, such as A. marinus or A. halophilus, which were 
isolated only in those environments. Furthermore, all sewage samples studied were 
positive for Arcobacter and showed a great diversity of species (Collado et al., 2008), 
among which the new species A. defluvii (Collado et al., 2010), indicating that sewage 
may be an important reservoir for these microbes. 
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These microbes can be isolated and detected from sewage without an enrichment step, 
due to their large abundance (Collado et al., 2008), contrasting with the low prevalence in 
human faeces. Its abundance in sewage could also be explained by the adaptation of 
Arcobacter to the cooler temperature of the sewage systems, a more “natural” habitat 
than the human host, but this remains to be demonstrated (Collado et al., 2011). 
Van Driessche and Houf (2008) demonstrated that the capacity of Arcobacter species to 
survive in water was influenced by the presence of organic matter and temperature, 
showing that under laboratory conditions Arcobacter species maintain viability at least 
for 250 days at 4 °C. The loss of culturability of this species in non-chlorinated water 
stored at 12 °C occurred after 21 days, while, according to other authors, it occurs after 3 
to 4 weeks on agar plates at 4 °C (Moreno et al., 2004; Cervenka 2007). It has been 
reported that A. butzleri has the ability to become viable but unculturable (VBNC) when 
subjected to different laboratory conditions (Fera et al., 2008), but this VBNC state has 
not yet been shown to occur in Arcobacter in natural aquatic environments. 
 
1.4.2 Arcobacter in food 
 
Animal-derived food products represent an important potential dissemination way for 
Arcobacter (Collado et al., 2010). This hypothesis relies on the abundance of those 
microbes in the intestinal tract and faecal samples of healthy farm animals and in many 
retailed meat products. It has been indicated that contamination of meat products by 
Arcobacter probably occurs when the faeces of contaminated animals comes into contact 
with the carcasses during the slaughtering process (Aydin et al., 2007).  
Arcobacter detection frequency in animal-derived foods is highest in poultry, followed by 
pork, beef products and raw milk. In the case of poultry, there has been some controversy 
about the origin of the contamination, because some authors suggested the slaughter 
environment was a source of Arcobacter (Van Driessche et al., 2007). However, other 
authors showed that these microbes inhabit the chicken intestine, indicating that the age 
of the sampled animals and the method used for recovery and identification influenced 
the results (Ho et al.,2008). 
According to the few existing studies, shellfish are another potential source of infection 
(Fernandez et al., 2001). In a study that investigated 84 samples of shellfish (shrimp, 
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mussels, clams, and oysters), 100% of the clams and 41.1% of the mussel samples 
showed a high abundance and a wide diversity of Arcobacter species (Collado et al., 
2009). Furthermore, the species A. mytili and A. molluscorum were first described from 
mussel samples (Figueras et al., 2012). This could have some public health importance, 
considering that seafood is often traditionally eaten undercooked or raw.  
Very recently, it was shown that Arcobacter is found not only in raw food products but 
also in meals at popular restaurants in Bangkok, with a higher abundance than other 
common enteropathogenic bacteria, such as Salmonella and Campylobacter (Teague et 
al.,2010). In food samples, the most frequent species found is A. butzleri, followed by A. 
cryaerophilus and A. skirrowii (Lehner et al., 2005; Pentimalli et al.,2009). According to 
such evidences, A. butzleri was included by the International Commission on 
Microbiological Specifications for Foods in the list of microbes representing a serious 
hazard to human health (ICMSF, 2002). However, it should be taken into consideration 
that more than one Arcobacter sp. is frequently isolated from food products (Houf et al., 
2002). 
 
1.4.3 Arcobacter in humans 
 
The species A. cryaerophilus, originally identified in 1988 as Campylobacter 
cryaerophila (Tee et al., 1988), was the first isolated from a human specimen. A. butzleri 
and A. cryaerophilus have been associated with gastrointestinal diseases both in 
population studies and in clinical cases (Vandenberg et al.,2004). Although 
microbiological and clinical characteristic were very similar, persistent watery diarrhoea 
was the main peculiar symptom associated with A. butzleri, in contrast to the bloody 
diarrhoea found in Campylobacter jejuni cases (Vandenberg et al.,2004). 
The isolation of Arcobacter species from faeces of healthy people, indicating 
asymptomatic carriage, has been reported only in a few studies: A. cryaerophilus was 
found in 1.4% of stool samples from asymptomatic workers in a slaughterhouse 
environment in Switzerland (Houf et al., 2007); human asymptomatic carriage of A. 
butzleri in Belgium was not significantly different compared to data on C. jejuni 
(Vandenberg et al.,2004). In South Africa, Arcobacter was detected in samples from 
asymptomatic people with a lower prevalence than in samples from people suffering 
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diarrhoea, among which 55.1% showed coinfection by two, three, or four pathogens, such 
as Arcobacter spp., C. jejuni, Campylobacter coli, Campylobacter concisus and 
Helicobacter pylori (Samie et al., 2007). Two patients showed A. butzleri and A. 
skirrowii coinfection with H. pylori (Samie et al. ,2007), which was found to be the 
etiological agent of traveller’s diarrhoea acquired by travellers to Mexico, Guatemala, 
and India (Jiang et al., 2010).  
 
1.4.4 Arcobacter in animals 
 
Arcobacter has been frequently isolated from the intestinal tracts and faecal samples from 
different farm animals, but it seems to be able to cause disease only in some individuals 
(Ho et al.,2006). The most serious effects of Arcobacter in animals include abortions, 
mastitis, and diarrhoea (Logan et al.,1982).  
Although Arcobacter has been associated several times with bovine (Neil et al., 1985) 
and porcine abortion, in the absence of reproductive problems (de Oliveira et al., 1997), 
these bacteria have also been recovered from healthy bovine preputial sheath washings 
(Gill, 1983), as well as from vaginal swabs from cows with no reproduction problems 
(Kabeya et al., 2003).  
A. cryaerophilus is the species predominantly linked to animal abortion, while A. butzleri 
and A. skirrowii are less frequent (On et al., 2003). A. butzleri has been associated with 
enteritis and diarrhoea in pigs, cattle, and horses, while A. skirrowii has been associated 
with diarrhoea and haemorrhagic colitis in sheep and cattle (Ho et al., 2006).  
Faecal shedding of Arcobacter is well known in poultry, i.e., chicken, ducks, turkeys and 
domestic geese, and the lack of reports of any association with disease in those animals 
suggested that poultry could be a natural reservoir of Arcobacter species (Lipman et al., 
2008). Some authors also consider pigs to be important hosts and reservoirs of 
Arcobacter species (Houf, 2010).  
Most clinical cases affecting animals are restricted to mammals, although one study 
(Yildiz et al., 2006) reported the isolation of A. cryaerophilus from a naturally infected 
rainbow trout (Oncorhynchus mykiss). The pathogenicity of the recovered strain was 
demonstrated by in vivo experimental infection, causing the death of the fish, which 




1.5 Bacterial resistance to antimicrobial drugs 
 
Since Alexander Fleming discovered penicillin, produced by Penicillium notatum, as the 
first antibiotic in modern medicine in 1928, antibiotics have been widely used for over 40 
years in both humans and animals (Alanis, 2005). The discovery of penicillin was 
followed by the discovery and commercial production of many other antibiotics.  
Antibiotics are manufactured at an estimated scale of about 100,000 tons annually 
worldwide, and their use had a profound impact on the life of bacteria on earth (Nikaido, 
2009). This increasing usage of antibiotics has led to a worldwide problem in the 
development of antibiotic resistance (AR) among bacterial populations during recent 
decades (Mathew et al., 2007; Shryock et al., 2010). Many pathogenic strains have 
developed antibiotic resistance and some of them became resistant to many antibiotics 
and chemotherapeutic agents, giving rise to the phenomenon of multidrug resistance. 
Indeed, some strains are resistant to most of the commonly available agents.  
A notorious case are the methicillin-resistant Staphylococcus aureus (MRSA) strains, 
which are resistant not only to methicillin (which was developed to fight against 
penicillinase-producing S. aureus) but usually also to aminoglycosides, macrolides, 
tetracycline, chloramphenicol and lincosamides. Such strains are also resistant to 
disinfectants, and MRSA can act as a major source of hospital-acquired infections. An 
old antibiotic, vancomycin, was resurrected for treating MRSA infections (de Lencastre 
et al., 2007). Another widely known case of antibiotic resistance was that of mutant 
strains of Mycobacterium tuberculosis resistant to therapeutic concentrations of 
streptomycin used for the treatment of tuberculosis in 1944 (TB; “The Great White 
Plague”) (Davies et al., 2010) .  
The unexpected identification of genetically transferable antibiotic resistance in Japan in 
the mid-1950s (initially greeted with scepticism in the West) (Davies, 1995) changed the 
whole picture by introducing the heretical genetic concept that collections of antibiotic 
resistance genes could be disseminated by bacterial conjugation throughout an entire 
population of bacterial pathogens (with a few notable exceptions) (Funnell, et al., 2004; 
Helinski, 2004). Only in the past few years it was accepted that gene exchange is a 
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universal property of bacteria and this event frequently occurred throughout microbial 
evolution. The discovery of the presence of putative bacterial gene sequences in 
eukaryotic genomes has heightened awareness of the great importance of horizontal gene 
transfer (HGT) in genome evolution. Subsequently, other aspects of gene transfer have 
been revealed by the identification and distribution of genomic islands carrying genes for 
pathogenicity (Hacker et al., 2000) and other functional gene clusters in different 
bacterial genera. Not surprisingly, plasmid-mediated transfer of antibiotic resistance has 
been a major focus of investigation because of its medical and, more recently, practical 
significance (Norman et al., 2009). 
Several mechanisms of antimicrobial resistance are readily spread to a variety of bacterial 
genera: the organism may express genes encoding enzymes, such as ß-lactamases, 
hindering the activity of the antibacterial agent; they may also acquire efflux pumps or 
express downregulation of porin genes excluding antibacterial agents from the cells 
before they can reach its target site or they may show altered metabolic pathways leading 
to the synthesis of modified cell walls that no longer contain the binding site of the 
antimicrobial agent. Thus, normally susceptible populations of bacteria may become 
resistant to antimicrobial agents through mutation and selection, or by acquiring from 
other bacteria the genetic information encoding resistance through mechanisms of 
transformation, conjugation or transduction.  
Mutation and selection, together with the mechanisms of genetic exchange, enable many 
bacterial species to adapt quickly to the introduction of antibacterial agents into their 
environment. Although a single mutation in a key bacterial gene may only slightly reduce 
the susceptibility of the host bacteria to that antibacterial agent, it may be just enough to 
allow its initial survival until it acquires additional mutations or additional genetic 
information resulting in full-fledged resistance to the antibacterial agent. However, in rare 
cases, a single mutation may be sufficient to confer high-level, clinically significant 
resistance upon an organism (e.g., high-level rifampin resistance in S. aureus or high-
level fluoroquinolone resistance in Campylobacter jejuni).  
Resistance to antimicrobial agents obtained by mutations may act through binding site 
modification (e.g., change in penicillin-binding protein 2b in pneumococci, which results 
in penicillin resistance) (Krause, 1992; McManus, 1997; National Nosocomial Infections 
Surveillance  -NNIS - System Report, 2004); by upregulating the production of enzymes 
that inactivate the antimicrobial agent (e.g., erythromycin ribosomal methylase in 
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staphylococci) (Chambers, 2001); by downregulating or altering an outer membrane 
protein channel required for drug cell entry (e.g., OmpF in E coli) or upregulating pumps 
that expel the drug from the cell (efflux of fluoroquinolones in S. aureus) (Edmond et 
al.,1999). In all cases, strains of bacteria carrying resistance-conferring mutations are 
selected by antimicrobial use, which kills the susceptible strains but allows the newly 
resistant strains to survive and grow. Acquired resistance due to chromosomal mutation 
and selection is termed vertical evolution, in contrast with the acquisition of new genetic 
material from other resistant organisms, which is termed horizontal evolution. 
In genetic exchange processes, transposons may facilitate the transfer and incorporation 
of the acquired resistance genes into the host’s genome or into plasmids. During 
conjugation, a gram-negative bacterium transfers plasmid-containing resistance genes to 
an adjacent bacterium, often via an elongated structure termed pilus, which joins the two 
organisms. Conjugation among gram-positive bacteria is usually initiated by production 
of sex pheromones by the mating pair, which facilitate the clumping of donor and 
recipient organisms, allowing the exchange of DNA. During transduction, resistance 
genes are transferred among bacteria via bacteriophages (bacterial viruses). This is now 
thought to be a relatively rare event. Transformation, i.e., the process whereby bacteria 
acquire and incorporate DNA segments released into the environment after cell lysis, can 
move resistance genes into previously susceptible strains.  
Bacteria with multidrug resistance (defined as resistance to more than 3 antibacterial drug 
classes) obtained by genetic exchange events have become a cause for serious concern, 
particularly in hospitals and other healthcare institutions where they commonly occur. 
The most serious consequence of the use of antibiotics is the concomitant development of 
resistant strains; this has prompted continuous efforts to exert control over antibiotic 
usage. Erythromycin was an early example, since it was introduced as an alternative to 
penicillin for the treatment of S. aureus in Boston City Hospital in the early 1950s and it 
was completely withdrawn after less than a year because 70% of all the S. aureus isolates 
were found erythromycin-resistant. The same was observed with chlortetracycline and 
chloramphenicol and, subsequently, with other antibiotics (Finland, 1979).  
Strict controls on antibiotic use by humans, requiring accurate prescriptions (no use of 
antibiotics to treat colds and other viral infections), no delivery of antibiotics without a 
doctor’s prescription (reducing needless use of antibiotics), and controlled therapeutic use 
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in animal husbandry and agriculture have been stated to reduce the occurrence of 
bacterial resistance.  
Novel semisynthetic compounds generated by chemical modifications of antibiotic core 
structures have extended the useful life of several classes, such as methicillin (oxacillin), 
the macrolide azithromycin, and the modified aminoglycoside amikacin, among others. 
Nevertheless, in some cases, chemical modification of antimicrobials led to enhanced 
toxicity and did not overcome completely the development of resistance.  
New therapeutic compounds able to interfere with efflux of active inhibitors from the cell 
have been designed, although a very few effective compounds have been obtained, and 
only one or two have come close to market (Lomovskaya et al., 2007).  
 
1.5.1 Antibiotic resistance in Arcobacter 
 
Like Campylobacter, the majority of cases of enteritis and bacteraemia caused by 
Arcobacter appear to be self-limiting and do not require antimicrobial treatment. 
However, the severity or prolongation of symptoms may justify the use of antibiotic 
treatments, the most commonly prescribed drugs being erythromicin or a fluoroquinolone 
such as ciprofloxacin (Luber et al., 2003). Tetracycline, doxycycline, and gentamycin are 
sometimes listed as alternative drugs for treatment. Several studies have shown that many 
A. butzleri strains are resistant to clindamycin, azithromycin, ciprofloxacin, 
metronidazole, carbenicillin, and cefoperazone (Teague et al., 2010). Fluoroquinolones 
and tetracycline have been suggested for the treatment of human and animal infections 
produced by Arcobacter (Son et al.,2007) because they showed good activity against 
strains of different origins (Vandenberg et al.,2006). However, strains resistant to 
nalidixic acid and ciprofloxacin have been detected (On et al.,1995; Abdelbaqi et 
al.,2007). 
Fluoroquinolone resistance in most bacterial species is due to mutations in the DNA 
gyrase and DNA topoisomerase IV genes (Aarestrup et al.,2001), large 
enzymatic quarternary structures consisting of two pairs of subunits, named GyrA and 
GyrB (DNA gyrase), and ParC and ParE (topoisomerase IV). Resistance to the 
fluoroquinolones arises from amino acid(s) substitution(s) in the quinolone resistance-
determining region (QRDR), located within the DNA-binding domain on the surface 
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of these enzymes. Reduction in susceptibility to the fluoroquinolones occurs after a first-
step mutation, with additional mutations in gyrA and gyrB or parC further increasing 
the level of resistance (Payot et al.,2006). In Campylobacter and Arcobacter, 
fluoroquinolone resistance appears to be due mainly to mutations in the gyrA gene 
encoding part of the gyrA subunit of DNA gyrase, e.g. resistance to ciprofloxacin in C. 
jejuni is conferred by the point mutation Thr-86-Ile in gyrA, which is homologous to Ser-
83-Leu in E. coli (Ge et al., 2005). Other  mutations of gyrA have been reported, like Thr-
86-Ala (high-level resistance to nalidixic acid and low-level resistance to ciprofloxacin), 
Ala-70-Thr, Thr-86-Lys, Asp-90- Asn, and Pro-104-Ser (Alfredson  et al., 2007). Double 
point mutations of gyrA combining Thr-86-Ile and Asp-85-Tyr, or Asp-90-Asn, or Pro-
104-Ser have also been reported (Ge et al., 2005).  
In C. jejuni and C. coli, like in some Arcobacter isolates, the absence of a secondary 
target for fluoroquinolones leads to a fluoroquinolone-resistant phenotype through the 
occurrence of a unique modification in the gyrA subunit (Payot et al., 2006). In fact, two 
A. butzleri strains and one A. cryaerophilus strain resistant to ciprofloxacin showed a 
mutation in the quinolone resistance-determining region (QRDR) of the gyrA gene 
(Abdelbaqi et al.,2007), which could also be present in other strains.  
Such C to T mutation in position 254 of the gyrA gene, observed in some resistant 
Arcobacter isolates, could be the cause of quinolones resistance as this change seems to 
be absent in susceptible isolates.  
Moreover, the A. butzleri strain used for the complete genome sequencing showed 
antibiotic resistance traits associated with the presence or absence of specific genes that 
regulate antibiotic susceptibility (Miller et al.,2007). 
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2. Aim of the work 
 
The aim of this work was the analysis of susceptibility of Arcobacter spp. isolates from 
different food samples, to different antimicrobial agents (Ciprofloxacin and 
Levofloxacin). Large amounts of antibiotics used for human and animal therapy, resulted 
in the selection of pathogenic bacteria resistant to multiple drugs. Multidrug resistance in 
bacteria may be generated by different genetic causes.  
The analysis of bacterial susceptibility, carried out by the use of discs and E-strips for 
both antibiotics, determined the minimum inhibitory concentration (MIC), defined as the 
lowest concentration of an antimicrobial agent giving total inhibition of visible bacterial 
growth.  
Moreover, the sequencing of quinolone resistance-determining region (QRDR) of the 
gyrA gene allowed the analysis of mutations possibly related to the development of 






















3. Materials and Methods  
 
For the development of this study the isolates used had been obtained from different 
marine samples such as clams, mussels and cockle. The isolates were preserved in 
cryovial at – 20°C. 
All the isolates were grown on Arcobacter Broth (Oxoid CM0965) with agar and 5%  
defibrinated sheep blood (Oxoid SR0075IC). The plates were incubated at 37 °C for 24 h 
under microaerophilic conditions (Oxoid CampyGen Sachets, Oxoid CN0035A). 
Arcobacter colonies are small, translucent, beige to off white, round with diameter about 
2-4 mm. Presumptive Arcobacter colonies were subjectd to Gram staining, after which 
Arcobacter cells appear as bacilli with spiral and curved shape, staining pink-red (Gram 
negative). 
A total of 61 isolates (Table 2) were revitalised and plated, though after plating, 
purification and Gram staining, only 17 isolates were considered Arcobacter. Then, 3 
plates of each isolate confirmed to belong to Arcobacter genus were prepared. One of the 



















Isolates Arcobacter spp.  Isolates Arcobacter spp.  Isolates Arcobacter spp. 
A1C2  -  A4C6  -  CH1C6  - 
A1C4  -  A4C7  -  CH3C2 +  
A1C6  -  A4C8  -  CH3C4 +  
A1C8  -  X9C1  -  CL1C2  - 
A2C6  -  X7C5  -  CL1C3  - 
A2C7  -  A5C1  -  CL1C4  - 
A2C8* +   A5C2 +   CL2C1  - 
A3C7  -  A5C3 +   CL2C2  - 
A3C8  -  A5C4  -  CL2C3 +  
A4C5  -  CH1C3  -  CL2C4  - 
Y3C2  -  A12C2  -  A15C2 +  
Y3C3  -  A12C3 +   A15C3 +  
Y4C2 +   A12C4  -  A15C4 +  
A9C1 +   CL7C3  -  CH9C1  - 
CH6C2  -  CL8C3  -  CH9C2  - 
CH6C3  -  X1C1  -  CH2C10  - 
CH6C4  -  A14C1 +   CH2C11  - 
CL6C2  -  A14C3 +   CH2C12  - 
CL6C3  -  CL9C1 +   CH2C13  - 
CL6C4  -  CL9C2* +      
A12C1  -  A15C1 +      
Table 2. 61 isolates 
* Isolates tested in preliminary analyses: those belonging to Arcobacter spp. were used in subsequent experiments. 
 
3.1.1 DNA extraction 
 
With the aim of confirming the identification of presuntive Arcobacter by molecular 
analyses, cells from exponentially growing pure cultures in liquid medium were 
harvested and resuspended in 500 µl of Tris-EDTA (TE) buffer and stored at -20 °C. 
DNA extraction was performed using a genomic DNA extraction Kit (GenElute Bacterial 
Genomic DNA Kit, Sigma-Aldrich). Bacterial Genomic DNA Kits provide a simple and 
convenient way to isolate pure DNA from cultured bacteria and contain all the reagents 
needed to isolate and purify genomic DNA from gram-negative bacteria. The first step 
obtained pelleted samples by centrifuging for 2 minutes at 12000-16000 g. After 
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suspending the pellet in 180 µl of lysis solution, 20 µl of proteinase K and 20 µl of 
RNase A solution mix, samples were incubated for 30 min at 55°C. After incubation, add 
200µl of solution C, vortex for 15 sec and then incubated at 55 °C for 10 min. In the 
meanwhile, binding columns were prepared by adding 500 µl of column preparation 
solution, centrifuging at 12000 g for 1 min and then removing eluate. Samples were 
added of 200 µl absolute ethanol and vortexed for 5-10 sec before being transferred into 
columns and centrifuged at 6500 g for 1 min, discarding the eluate. Columns were then 
transferred on a new 2 ml tube and 500 µl wash solution were added, followed by 
centrifuging at 6500 g for 1 min. After discarding eluate, 500 µl wash solution were 
added and tubes were spinned 3 min at maximum speed (16000 g ). After eluate 
discarding a maximum speed centrifugation for 1 min was performed to remove the 
remaining ethanol. Each column was transferred to a new 2 ml collection tube, added 
with 200 µl of elution solution directly onto the centre of the column, incubated for 5 min 
at room temperature and centrifuged for 1 min at 65000 g to elute the DNA. Purified 
DNA was stored at -20°C. 
 
3.1.2 23s rDNA amplification 
 
PCR is a molecular biology technique used to amplify a single or a few copies of 
DNA sequences, generating thousands to millions DNA copies. This method was 
developed in 1983 by Karl B. Mullis who won, for this, the Nobel Prize for Chemistry 
(1993).  It  is based on repeated cycles of DNA denaturation, annealing of primers (short 
DNA fragments) to DNA stands and polymerization by Taq Dna polymerase which adds 
nucleotides complementary to the target sequence. 
Although in these analyses we can't distinguish if the amplified DNA fragment is 
originated form living, death or non-culturable cells, an enrichment step prior to DNA 
extraction leads to the increase of living cells, while dead cell and inhibitors are diluted, 
allowing the preferential detection of DNA from living microorganisms. The preparation 
of appropriate quality controls allows to evaluate the specificity of the method, and to 
highlight the presence of false positives or false negatives we used positive and negative 
controls, consisting of samples containing the target sequence and samples where any 
DNA was missing, to detect contaminations raised during the extraction of genomic DNA 
or the PCR preparation. 
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Detection of Arcobacter by PCR was performed using the ARCO1 (5’-
GTCGTGCCAAGAAAAGCCA-3’)  and ARCO2 (5’-TTCGCTTGCGCTGACAT-3’)  
primers (Bastyns et al., 1995), targeting a 331-bp fragment of 23S rDNA gene. Positive 
control is represented by Arcobacter butzleri NCTC 12481. 
The PCR mixture (total volume 25 µl) consisted of:  
  Buffer 1X; 
  100µM dNTPs ; 
  2 mM MgCl2; 
  2.5 U Taq Dna Polymerase;   
  0.5 µM each primer; 
  5 µl extracted DNA. 
 
The PCR was performed in a thermal cycler (Eppendorf), programmed as follows: initial 
denaturation of 5 min at 94 °C, 27 amplification cycles (1 min at 94 °C denaturation, 1 
min at 61 °C annealing and 1 min at 72 °C extension), final extension of 5 min at 72 °C. 
Electrophoresis is an analytical technique based on the separation and analysis of 
macromolecules (DNA, RNA and proteins) and their fragments, based on their size and 
charge. Using an electric field, molecules (such as DNA) move through an agarose or 
polyacrylamide gel. The gel is placed in an electrophoresis chamber connected to a power 
source and when the electric current is applied, large molecules move slower through the 
gel than the small molecules, forming distinct bands on the gel. Buffers in gel 
electrophoresis are used to provide ions that carry a current and to maintain the pH at a 
relatively constant value. The Buffer used in this work is TAE, consisting of a solution of 
Tris-acetate, generally at ph 8, and EDTA, which sequester the divalent cations. Agarose 
is a water-soluble (at boiling temperature) linear neutral polysaccharide formed by D-
galactose and 3,6-anhydro-L-galactose units and turn solid as it cools, forming a matrix 
by means of hydrogen bindings between the linear chains. After the electrophoresis is 
complete, the molecules in the gel can be stained by using different types of dyes, among 
which the most frequently used is Ethidium Bromide, fluorescent under ultraviolet light 
(300nm) when intercalating nucleotide molecules. Since Ethidium Bromide is a very 
effective mutagen and can induce carcinogenic effects, we used a non-toxic stain, 
RedSafe Nucleic Acid Staining Solution [20,000x], which show the same efficacy. 
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PCR products (12 µl) were detected by electrophoresis on 1.2% agarose gel in 1xTris-
Acetate-EDTA(TAE) buffer at 90 V for 45 min, and visualized by UV transillumination 
after staining with RedSafe. A 100-bp DNA ladder (Fermentas, Burlington, Canada) was 
used as a molecular weight marker. 
The following putative Arcobcter isolates were used for PCR confirmation: A2C8, A5C2, 
A5C3, A9C1, A12C3, A14C1, A14C3, A15C1, A15C2, A15C3, A15C4, CH3C2, CH3C4, 




3.2 Determination of antimicrobial susceptibility 
 
Sample colonies were suspended in 1.5 ml Arcobacter broth (Oxoid, CM0965) to the 0.5 
grade of McFarland turbidity scale. This suspension was spread with a sterile cotton tip 
over the entire surface of Arcobacter agar plates, then discs or strips containing 
antibiotics were applied onto the agar surface and plates were incubated at 37 °C under 
microaerophilic conditions for 48h. After 48h incubation, the diameter of the inhibition 
zones was measured with callipers. A disc diffusion zone of 6 mm or smaller indicates 
antimicrobial resistance and require the minimal inhibitory concentration (MIC) 
determination for accurate categorization of susceptibility. The MIC was defined as the 
lowest concentration of an antimicrobial agent giving total inhibition of visible bacterial 
growth. In our work, the use of antibiotic strips allowed the determination of MIC values 
by reading the concentration value corresponding to the point where the elliptical zone of 
inhibition intersected the concentration scale on the strip. The following resistance 
breakpoints were used in this study: MIC value ≤ 1µg/ml indicates susceptibility, MIC > 
4 µg/ml indicates resistance and values between 1- 4 indicates intermediate behaviour. 
The antimicrobial agents used in this study were Ciprofloxacin and Levofloxacin.  
Tests carried out by the disc method used 6 mm diameter discs containing Ciprofloxacin 
5 µg/disc (BBL™- Sensi Disc) or Levofloxacin 5 µg/disc (BD-BBL™ Sensi Disc), 
whereas in tests carried out with strips the E-test® strips of Ciprofloxacin 0.002 to 32 
µg/ml or Levofloxacin  0.002 to 32 µg/ml (Biomérieux) were used. 
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3.3 Molecular characterization of sensible and resistant strains 
3.3.1 Amplification and sequencing of the quinolone resistance-
determining region (QRDR) of the gyrA gene 
 
The mechanism of quinolone resistance was carried out by sequence determination and 
analysis of the QRDR of their gyrA gene. 7 isolates (A5C3, A12C3, A14C1, A14C3, A15C1, 
CH3C2, CL9C1) selected on the basis of antimicrobial resistance tests were used to carry 
out PCR amplification using the following mixture in a total volume of 25 l: 
  Buffer 1X; 
  0.2 M dNTPs; 
  2 mM MgCl2; 
  2.5 U Taq Dna Polymerase;   
  0.5 M each primer; 
  5 l DNA. 
The primers F-QRDR (5’ –TGG ATT AAA GCC AGT TCA TAG AAG- 3’) and R2-
QRDR (5’ –TCA TMG WAT CAT AAT TTG GWA C-3’), targeting a 344-bp fragment 
of gyrA gene (Abdelbaqii et al., 2007) were used. 
The amplification was performed in a thermal cycler (Eppendorf), programmed as 
follows: 5 min at 95 °C initial denaturation, 35 amplification cycles (30 sec at 95 °C 
denaturation, 30 sec at 57 °C annealing and 2 min at 72 °C extension), 8 min at 72 °C 
final extension. 
PCR products (12l) were detected by electrophoresis on 1.2% (w/v) agarose gel in 1x 
TAE buffer at 90 V for about 45 min, and visualized by UV transillumination after 
staining with RedSafe. A 100-bp DNA ladder (Fermentas) was used as a molecular 
weight marker.  
The GenElute PCR Clean-Up Kit (SIGMA
®
) was used for purification of PCR 
amplification products from other components in the reaction, such as excess primers, 
nucleotides, DNA polymerase, oil and salts. GenElute PCR mini spin columns were 
inserted into a provided collection tube, 0.5 ml of the Column Preparation Solution were 
added to each mini spin column and centrifuged at 12,000 g for 30 sec to 1 min. After 
discarding the eluate, Binding Solution was mixed with PCR products (5:1 vol/vol) and 
centrifuged at maximum speed (12,000-16,000 g) for 1 min. The binding column was 
transferred to a new collection tube and 0.5 ml of Wash Solution were applied to the 
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column, followed by centrifugation at maximum speed (12,000-16,000 g) for 1 min. 
After discarding the eluate, the binding column was centrifuged at maximum speed for 2 
min, to remove excess ethanol, then transferred to a new 2 ml collection tube and added 
with 50 ml of Elution Solution. After 1 min incubation at room temperature, the column 
was centrifuged at maximum speed, to elute purified DNA.  
The purified PCR product were sequenced by “ Servicios de secuenciación IBMCP”. 
 
 
3.3.2 Sequence analysis 
 
The Arcobacter origin of DNA sequences obtained was verified by using the BLAST 
program of National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/) and search for closely related sequences was carried out. 
Before phylogenetic analysis, forward and reverse sequences were merged and screened 
with Chimera Check version 2.7 (Cole et al., 2003) (http://rdp.cme.msu.edu).  
Sequences were then aligned with those retrieved from NCBI database using the software 
ClustalW (Chenna et al., 2003). A phylogenetic tree was performed using Treecon for 
Windows version 1.3b, with the Neigbor-joining algorithm and setting the Kimura model 
to 2 (Van de Peer & De Wachter, 1994). The confidence of branching was assessed using 














4. Results and discussion 
4.1 Molecular identification of strains 
 
17 isolates (A2C8, A5C2, A5C3, A9C1, A12C3, A14C1, A14C3, A15C1, A15C2, A15C3, 
A15C4, CH3C2, CH3C4, CL2C3, CL9C1, CL9C2, Y4C2), presumably belonging to 
Arcobacter after Gram staining and microscopy, were submitted to PCR confirmation of 
taxonomical identification. 
The primers set ARCO1 (5’-GTCGTGCCAAGAAAAGCCA-3’)  and ARCO2 (5’-
TTCGCTTGCGCTGACAT-3’)  targeted a 331-bp fragment of 23S rDNA gene, and the 
electrophoretic analysis of amplicons showed the occurrence of such fragment both in 
tested isolates and in positive control represented by Arcobacter butzleri NCTC 12481 
(Fig. 2). 




Figure 2. Amplification of a 331-bp fragment of 23S rDNA gene identifying Arcobacter isolates. Lanes 1 
and 13, 100 bp DNA ladder; lanes 2-11: A2C8, A5C2, A5C3, A9C1, A12C3, A14C1, A14C3, A15C1, A15C2, 
A15C3, lane 12: negative control. 
 
4.2 Determination of antimicrobial susceptibility 
 
The agar disk diffusion assay was the method of choice to detect the activity of the 
different antibiotics by measuring the size of the inhibition zone produced. In the current 
study, only 5 out of 15 isolates of Arcobacter spp. revealed resistance towards antibiotics 
tested, whereas some of them showed intermediate behaviour (Tables 1-2).  
Interestingly, only some isolates showed consistent results after disc inhibition and MIC 
assessments, confirming previous results reporting a differential response of bacterial 
331 bp 
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isolates when assessing their resistance to antimicrobial compounds using different 
assays (Karatuna, 2012).  
 
Ciprofloxacin 
  Disc assay MIC 
A12C3 R R 
A14C1 S I 
A14C3 S I 
A15C1 R R 
A15C2 S S 
A15C3 S S 
A15C4 S S 
A5C2 S S 
A5C3 R S 
A9C1 S S 
CH3C2 R R 
CH3C4 S S 
CL2C3 S S 
CL9C1 S S 
Y4C2 S S 
 
Table 2. Results of Ciprofloxacin susceptibility tests carried out by the disc-diffusion method and by MIC 
E-test. R, resistant ; S, sensitive ; I, intermediate 
 
 
The isolates A12C3, CH3C2 and A15C1 displayed resistance towards Ciprofloxacin both 
when using disc assay and when performing MIC determination, whereas the isolate 
A5C3 was resistant to such antimicrobial only when tested by the disc method (Table 2). 
The strains A14C1 and A14C3 showed intermediate behavior in the MIC determination, 
with growth inhibition at values of 3 and 1.5 mg/ml, respectively. 
Resistance to Levofloxacin was detected with both methods only for isolate CH3C2 
(Table 3). However, four other isolates were found resistant after disc assay and one 
more, CL9C1, after MIC assessment (Table 2). The strains A14C1 and A14C3, showing 
intermediate behavior in the MIC determination, displayed inhibition zones smaller than 









 Disc assay MIC 
A12C3 R S 
A14C1 R I 
A14C3 R I 
A15C1 S S 
A15C2 S S 
A15C3 S S 
A15C4 S S 
A5C2 S S 
A5C3 R S 
A9C1 S S 
CH3C2 R R 
CH3C4 S S 
CL2C3 S S 
CL9C1 S R 
Y4C2 S S 
 
Table 3. Results of Levofloxacin susceptibility tests carried out by the disc-diffusion method and by MIC 
E-test. R, resistant ; S, sensitive ; I, intermediate. 
 
4.3 Molecular characterization of sensible and resistant strains 
 
Since most Arcobacter are resistant to macrolides, fluoroquinolones are potential drugs 
for treatment and good performance of ciprofloxacin against A. butzleri and A. 
cryaerophilus was reported. The sequencing of the quinolone resistance determining 
region (QRDR) of the gyrA gene was carried out on strains showing 
resistance/intermediate behavior in the disc/MIC assays, since resistance may occur due 
to mutations in the QRDR. A 344-bp fragment of gyrA gene was amplified from the 
isolates (Fig. 3).  
 
 
Figure 3. Amplification of a 344-bp fragment of the gyrA gene containing the QRDR. Lanes 1 and 10: 100-





The sequencing of the 344-bp PCR product revealed a mutation in position 254 of the 
gyrA gene in 2 Arcobacter isolates, similarly to the resistant strain from which the 
sequence DQ464332 was obtained (Fig. 4). This 254C-to-T mutation, leading to  
Threonine-85-Isoleucine change in protein (Fig. 5), could be the cause of the 
resistant/intermediate behaviour recorded in A14C3 in the presence of levofloxacin. 
Accordingly, it has been reported that in three quinolone-resistant Arcobacter strains, 
sequencing revealed a C-T transition in position 254 of the gyrA gene, leading to an 
amino acid substitution in position 85 (Thr-Ile) of the deduced corresponding protein 
(Abdelbaqi et al., 2007b). 
Bacterial DNA gyrase is essential for bacterial viability since it catalyzes ATP-dependent 
negative supercoiling of DNA and is involved in DNA replication, recombination, and 
transcription. Gyrase consists of subunits A and B which are encoded by gyrA and gyrB. 
The gyrA gene is important tool for bacterial phylogeny and it was used to identify 
species belonging to several groups such as Enterobacteriaceae (Wertz et al., 2003), 
Bacillus (Chun and Bae, 2000), and Klebsiella (Brisse and Verhoef, 2001). 
In Campylobacter, the resistance to fluoroquinolones is mediated by point mutations in 
the QRDR of gyrA in conjunction with the function of the multidrug efflux pump 
CmeABC (Han et al., 2012). Specific mutations at positions Threonine-86, Asparagine-
90, and Alanine-70 in gyrA have been linked to resistance to fluoroquinolones in C. jejuni 
(Luo et al., 2003; Han et al., 2012). The Threonine-86-Isoleucine change (induced by the 
C257T mutation in the gyrA gene) is the most commonly observed mutation in resistant 
Campylobacter isolates and confers high-level ciprofloxacin resistance, whereas the 
Threonine-86-Lysine and Aspartate-90-Asparagine mutations are less common and are 
associated with intermediate-level resistance (Luo et al., 2003). 
In Salmonella spp., site-directed mutagenesis of gyrA resulting in a substitution of Serine 
with Phenylalanine and of Glycine with Aspartate at position 83 and 87, respectively, 
induced lower susceptibility to ciprofloxacin, nalidixic acid and triclosan than those of 
their parental strain (Webber et al., 2013). Both Salmonella spp. and Escherichia coli 
gyrA mutants showed reduced degree of DNA supercoiling, due to increases in gyrA 
expression and decreases in topA expression (Menzel and Gellert, 1987; Webber et al., 
2013). Altered DNA supercoiling seems to act as a signal of stress, inducing the 
expression of specific sigma-factors and of recA protein (involved in DNA damage 
repair), altered expression of genes encoding components of multi-drug efflux pump, 
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reduced expression of pathogenicity island genes (Webber et al., 2013). Such an 
influence on cell stress metabolic network may represent the key factor affecting mutant 
strain physiology, both regarding drug susceptibility and fitness. 
In the present work, A-G mutation in QRDR of gyrA sequences at position 290, 
originating change in Asparagine to Serine in protein sequence at position 96, was 
detected in A15C1, A14C3 and A14C1 isolates (Fig. 5). It is possible that the resistance to 
ciprofloxacin detected in disc and MIC assays of isolate A15C1, lacking the DNA 254C-
to-T mutation, is due to this further change in protein composition. 
The DNA sequence of isolate CL9C1, lacking both 254C-to-T and 290A-to-G mutation, 
showed two A-G mutations, causing Leucine to Methionine (position 99) and Asparagine 
to Serine (position 117) changes in the protein (Fig. 5), but only a limited resistance of 
this strain was suggested by the MIC assay of levofloxacin. The same kind of changes 
were detected in Arcobacter skirrowii type strain 449/80  gyrA sequence (DQ464338), 
and such strain was reported to be susceptible to Nalidixic acid and Cephalothin 
(Vandamme et al., 1992). On the contrary, responses to antimicrobials of the Arcobacter 
cryaerophilus strain 622H-2004, showing Asparagine to Serine (position 96 and 117) and  
Leucine to Methionine (position 99) changes in gyrA sequence (ABF06588) are not 
known, and Arcobacter cibarius showing Threonine-86-Serine in position 85 of the gyrA  
was found susceptible to ciprofloxacin. 
The nucleotide changes observed were presumed not to be due to Taq polymerase errors, 
since their occurrence should be much more lower (0.007 errors in the whole sequence), 
and the changes occur in more than one sequence each. 
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CLUSTAL O(1.2.0) multiple sequence alignment 
 
DQ464334 S                AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
DQ464332 R                AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATATTTC 
A14c3 R                   AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATATTTC 
A12c3 S                   AAAATCTGCAAGAATTGTAGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
A15c1 S                   AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
A14c1 R                   AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATATTTC 
CH3c2 S                   AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
CL9c1 S                   AAAATCAGCAAGAATTGTTGGAGACGTAATAGGAAAATATCACCCTCATGGTGATACTTC 
DQ464338 S                AAAATCAGCAAGAATTGTTGGAGATGTAATTGGTAAGTACCATCCACACGGAGATACTTC 
DQ464334:123-424 S        AAAATCTGCAAGAATTGTTGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
A5c3 S                    AAAATCTGCAAGAATTGTAGGAGATGTTATTGGTAAATATCACCCTCATGGAGATACTTC 
                          ******:***********:***** **:**:**:**.** ** **:** **:**** *** 
 
DQ464334                  AGTTTATGATGCACTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCTCCACTTGTTGA 
DQ464332                  AGTTTATGATGCACTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCTCCACTTGTTGA 
A14c3                     AGTTTATGATGCACTTGTAAGAATGGCACAAAGTTTCTCTTTAAGAGCACCACTTGTTGA 
A12c3                     AGTTTATGATGCCCTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCACCACTTGTTGA 
A15c1                     AGTTTATGATGCACTTGTAAGAATGGCACAAAGTTTCTCTTTAAGAGCACCACTTGTTGA 
A14c1                     AGTTTATGATGCACTTGTAAGAATGGCACAAAGTTTCTCTTTAAGAGCACCACTTGTTGA 
CH3c2                     AGTTTATGATGCACTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCTCCACTTGTTGA 
CL9c1                     TGTTTATGATGCCCTTGTAAGAATGGCTCAAAATTTCTCTATGAGAGCTCCTTTAGTTGA 
DQ464338                  TGTTTATGATGCACTTGTAAGAATGGCTCAAAACTTCTCTATGAGAGCACCACTTGTTGA 
DQ464334:123-424          AGTTTATGATGCACTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCTCCACTTGTTGA 
A5c3                      AGTTTATGATGCCCTTGTAAGAATGGCACAAAATTTCTCTTTAAGAGCACCACTTGTTGA 
                          :***********.**************:****. ******:*.*****:**: *:***** 
 
DQ464334                  TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCGGCTATGAGATATACAGA 
DQ464332                  TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCGGCTATGAGATATACAGA 
A14c3                     TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCAGCTATGAGATATACAGA 
A12c3                     TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCGGCTATGAGATATACAGA 
A15c1                     TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCAGCTATGAGATATACAGA 
A14c1                     TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCAGCTATGAGATATACAGA 
CH3c2                     TGGACAAGGAAACTTTGGTTCTATCGATGGTGACAATGCAGCGGCTATGAGATATACAGA 
CL9c1                     TGGACAAGGAAACTTTGGTTCTATCGATGGAGATAGTGCTGCTGCTATGAGATATACGGA 
DQ464338                  TGGTCAAGGAAACTTTGGTTCTGTTGATGGCGATAGTGCAGCTGCTATGAGATATACAGA 
DQ464334:123-424          TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCGGCTATGAGATATACAGA 
A5c3                      TGGACAAGGAAACTTTGGTTCTATCGATGGTGATAATGCAGCGGCTATGAGATATACAGA 
                          ***:******************.* ***** ** *.***:** **************.** 
 
DQ464334                  AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
DQ464332                  AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
A14c3                     AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
A12c3                     AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
A15c1                     AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
A19c1                     AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
CH3c2                     AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATAAAGATACAGTAAA 
CL9c1                     AGCTAGAATGACTAGAATAGCTGAAGAAGTATTAAGAGATTTGGATAAAGATACAGTTAA 
DQ464338                  AGCTAGAATGACAAGAATTGCTGAAGAGGTTTTACGAGATTTAGATAAAGATACAGTAAA 
DQ464334:123-424          AGCTAGAATGACAAGAATTGCTGAAGAAGTTCTAAGAGATTTAGATA------------- 
A5c3                      AGCTAGAATGACAAGAATTGCTGAAGAAGTCTAAGAGATTAGATAGGAGCATGG------ 
                          ************:*****:********.**  :* ...:*: . * .              
 
Figure 4. DNA sequence alignment of the quinolone resistance-determining region domain of the gyrA 
genes of Arcobacter spp. strains from the present work (boldface) and reference sequences to compare 
quinolone-susceptible (S) and resistant (R) strains, showing the C-to-T mutation.  
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CLUSTAL O(1.2.0) multiple sequence alignment 
 
DQ464332      KSARIVGDVIGKYHPHGDISVYDALVRMAQNFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
A12c3         KSARIVGDVIGKYHPHGDTSVYDALVRMAQNFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
CH3c2         KSARIVGDVIGKYHPHGDTSVYDALVRMAQNFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
DQ464334      KSARIVGDVIGKYHPHGDTSVYDALVRMAQNFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
A14c3         KSARIVGDVIGKYHPHGDISVYDALVRMAQSFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
A14c1         KSARIVGDVIGKYHPHGDISVYDALVRMAQSFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
A15c1         KSARIVGDVIGKYHPHGDTSVYDALVRMAQSFSLRAPLVDGQGNFGSIDGDNAAAMRYTE 60 
ABF06588      KSARIVGDVIGKYHPHGDTSVYDALVRMAQSFSMRAPLVDGQGNFGSVDGDSAAAMRYTE 60 
CL9c1         KSARIVGDVIGKYHPHGDTSVYDALVRMAQNFSMRAPLVDGQGNFGSIDGDSAAAMRYTE 60 
DQ464338      KSARIVGDVIGKYHPHGDTSVYDALVRMAQNFSMRAPLVDGQGNFGSVDGDSAAAMRYTE 60 
              ****************** ***********.**:*************:***.******** 
 
DQ464332      ARMTRIAEEVLRDLDKDTVNFVPNY 85 
A12c3         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
CH3c2         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
DQ464334      ARMTRIAEEVLRDLDKDTVNFVPNY 85 
A14c3         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
A14c1         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
A15c1         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
ABF06588      ARMTRIAEEVLRDLDKDTVNF---- 81 
CL9c1         ARMTRIAEEVLRDLDKDTVNFVPNY 85 
DQ464338      ARMTRIAEEVLRDLDKDTVNFVPNY 85 
             **********************     
Threonine to Isoleucine 
Asparagine to Serine 
 
 
Figure 5. Arcobacter GYR A sequence alignment highlighting the different aminoacid changes in yellow 
(Thr-to-Ile), green (Asn-to-Ser). 
 
Interestingly, strains A12C3, A5C3 and CH3C2, which showed resistance to quinolones 
during in vitro assays, displayed susceptible genotype when comparing gyrA sequences, 
suggesting that other genetic targets have to be studied to explain such behaviour. 
It would be interesting to compare strains carrying multiple sequence changes, on the basis 
of both susceptibility to antimicrobials and in vivo and in vitro cell fitness, since alteration 
in DNA supercoiling status may affect the physiology and fitness of bacterial organisms. 
Accordingly, the Threonine-86-Isoleucine change in GyrA was correlated with fitness 
changes in Campylobacter and greatly reduced the supercoiling activity of gyrA, while 
other mutations, although reducing the susceptibility of Campylobacter to ciprofloxacin, 
did not affect the supercoiling activity of DNA gyrase (Han et al., 2012). In S. 
typhimurium, highly quinolone-resistant mutants selected in vitro grew significantly slow 
in culture media, and failed to colonize chickens, whereas in vivo selected isolates showed 
intermediate susceptibility to quinolones, regular growth in liquid medium and an efficient 
ability to colonize chickens (Giraud et al., 2003; Zhang et al., 2006).  
E. coli single mutations in DNA gyrase conferred a low-level resistance to quinolones and 
did not affect fitness, while accumulation of multiple mutations resulted in higher 
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resistance accompanied by a significant fitness reduction (Morgan-Linnell and 
Zechiedrich, 2007; Marcusson et al., 2009). 
The evidences that changes to gyrase A gene can alter antimicrobial susceptibility, 
suggests that such environmental microbial strains may acquire a selective advantage 
growing in the presence of low levels of antimicrobial molecules, either synthetic or 
produced by hosts or neighbours, and that an increasing resistance to antibiotics, spreading 
among Epsilonproteobacteria, may represent a public health concern. 
 
 
Figure 6. Phylogenetic analysis of partial GyrA gene sequences obtained from this work (boldface) and from 
NCBI, generated with the neighbor-joining method (Kimura=2), with Campylobacter jejuni subsp. jejuni 
used as outgroup. Numbers next to each node indicate bootstrap values as a percentage of 100 replicates. 
 
 
The 16S rRNA gene sequence has been the basis for bacterial taxonomy and has proved to 
be highly accurate, although a low discriminant power was reported 
for Epsilonproteobacteria  (Dewhirst et al., 2005). In some taxa, the gyrA gene sequence 
seems to represent an important tool for bacterial phylogeny and it has been used 
to identify enteric bacteria, Bacillus spp. and Klebsiella spp. and to differentiate 
Campylobacter species (Wilson et al., 2000).  
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In this study, the phylogenetic analyses of partial gyrA gene and encoded gyrA protein  
of Arcobacter strains allowed optimum separation of these isolates from the related species 
Campylobacter jejuni (Figs 6-7), although the discrimination between sequences belonging 
to A. butzleri and the similar specie A. cryaerophilus and A. skirrowi is not supported by 
high bootstrap values, maybe due to the limited sequence length analysed.  
A recent study demonstrated the presence of putative virulence genes associated with both 
adhesion and invasion of human cell lines in vitro for nearly all the Arcobacter species, 
using strains isolated from various sources, confirming their potential as human pathogens 
and suggesting a particular virulence for some strains belonging to A. butzleri, A. 
cryaerophilus, A. skirrowii, A. trophiarum and A. defluvii (Levican et al., 2013). In this 
view, sequencing of the complete gyrA gene in other species in the 
Epsilonproteobacteriaceae group may be useful to implement our discrimination power 
among Arcobacter species and isolates, and both parent and mutant sequences may 
represent good targets to develop real-time PCR assays to identify Arcobacter species. 
Such technique would allow to evaluate  the occurrence of this probably underestimated 
emerging pathogen, lacking of appropriate culture conditions and identification methods, 







Figure 7. Phylogenetic analysis of predicted gyrA protein sequences from the ORF obtained from this work 
(boldface) and from NCBI, generated with the neighbor-joining method (Kimura=2), with Campylobacter 















In conclusion, results obtained by in vitro antibiotic susceptibility tests carried out on 
Arcobacter spp. isolated from seafood showed resistance to the antimicrobial agents 
Ciprofloxacin (4 isolates) and Levofloxacin (6 isolates). Moreover, a determinant for 
resistance was detected in the 344-bp fragment of the QRDR of the gyrA gene, where 
mutations in position 254 and 290 of the gyrA gene possibly conferring lower 
susceptibility to fluoroquinolones were found in 2 and 3 Arcobacter isolates, respectively. 
These mutations involve changes in aminoacidic sequence of the protein, which show a 
Threonine to Isoleucine or an Asparagine to Serine mutation: the former transition has 
been reported to occur in resistant isolates, whereas the latter has not been found 
previously. 
Since Arcobacter is a emergent enteropathogen, information about the susceptibility of 
foodborne or environmental isolates  to antimicrobial agents is needed for efficient 
treatment of associated diseases. Moreover, these data are useful to monitor the increase of  
antibiotic resistance phenomena in human pathogenic bacteria, which represent a major 
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